---
figid: PMC5837124__41392_2018_8_Fig3_HTML
figlink: /pmc/articles/PMC5837124/figure/Fig3/
number: F3
caption: Various strategies to target Myc. Inhibitors of BRD4, CDK7, and CDK9 inhibit
  MYC expression at the transcriptional level. Inhibition of the PI3K/AKT/mTOR pathway
  blocks MYC translation, whereas USP7, AURKA, and PLK1 inhibitors destabilize Myc
  at the posttranslational level. 10058-F4 and Omomyc function to interrupt the Myc–Max
  dimeric complex. BRD4 bromodomain-containing 4, CDK7 cyclin-dependent kinase 7,
  CDK9 cyclin-dependent kinase 9, PLK1 polo-like kinases 1, PI3K/AKT/mTOR phosphatidylinositol
  3-kinase/AKT/mammalian target of rapamycin
pmcid: PMC5837124
papertitle: Targeting oncogenic Myc as a strategy for cancer treatment.
reftext: Hui Chen, et al. Signal Transduct Target Ther. 2018;3:5.
pmc_ranked_result_index: '133118'
pathway_score: 0.956781
filename: 41392_2018_8_Fig3_HTML.jpg
figtitle: Various strategies to target Myc
year: '2018'
organisms:
- Homo sapiens
ndex: 1425f2c0-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5837124__41392_2018_8_Fig3_HTML.html
  '@type': Dataset
  description: Various strategies to target Myc. Inhibitors of BRD4, CDK7, and CDK9
    inhibit MYC expression at the transcriptional level. Inhibition of the PI3K/AKT/mTOR
    pathway blocks MYC translation, whereas USP7, AURKA, and PLK1 inhibitors destabilize
    Myc at the posttranslational level. 10058-F4 and Omomyc function to interrupt
    the Myc–Max dimeric complex. BRD4 bromodomain-containing 4, CDK7 cyclin-dependent
    kinase 7, CDK9 cyclin-dependent kinase 9, PLK1 polo-like kinases 1, PI3K/AKT/mTOR
    phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - CDK9
  - BRD4
  - AKT2
  - MAX
  - MYC
  - CDK7
  - AURKA
  - AKT1
  - USP7
  - PLK1
  - BEZ235
  - 10058-F4
  - BI2536
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CDK9
  symbol: CDK9
  source: hgnc_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Max
  symbol: MAX
  source: hgnc_symbol
  hgnc_symbol: MAX
  entrez: '4149'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CDK7
  symbol: CDK7
  source: hgnc_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: AURKA
  symbol: AURKA
  source: hgnc_symbol
  hgnc_symbol: AURKA
  entrez: '6790'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: PLK1
  symbol: PLK1
  source: hgnc_symbol
  hgnc_symbol: PLK1
  entrez: '5347'
chemicals:
- word: BEZ235
  source: MESH
  identifier: C531198
- word: 10058-F4
  source: MESH
  identifier: C524814
- word: BI2536
  source: MESH
  identifier: C518477
diseases: []
figid_alias: PMC5837124__F3
redirect_from: /figures/PMC5837124__F3
figtype: Figure
---
